N-[(1s)-1-[[[(5s)-5-[[(4-氨基苯基)磺酰基](2-甲基丙基)氨基]-6-羟基己基]氨基]羰基]-2,2-二苯基乙基]氨基甲酸甲酯

更新时间:2024-01-02 22:22:42

N-[(1s)-1-[[[(5s)-5-[[(4-氨基苯基)磺酰基](2-甲基丙基)氨基]-6-羟基己基]氨基]羰基]-2,2-二苯基乙基]氨基甲酸甲酯结构式
N-[(1s)-1-[[[(5s)-5-[[(4-氨基苯基)磺酰基](2-甲基丙基)氨基]-6-羟基己基]氨基]羰基]-2,2-二苯基乙基]氨基甲酸甲酯结构式
品牌特惠专场
常用名 N-[(1s)-1-[[[(5s)-5-[[(4-氨基苯基)磺酰基](2-甲基丙基)氨基]-6-羟基己基]氨基]羰基]-2,2-二苯基乙基]氨基甲酸甲酯 英文名 PL-100 PL100
CAS号 612547-11-2 分子量 624.79100
密度 N/A 沸点 N/A
分子式 C33H44N4O6S 熔点 N/A
MSDS N/A 闪点 N/A

 名称

中文名 N-[(1s)-1-[[[(5s)-5-[[(4-氨基苯基)磺酰基](2-甲基丙基)氨基]-6-羟基己基]氨基]羰基]-2,2-二苯基乙基]氨基甲酸甲酯
英文名 N-[(5S)-5-{[(4-Aminophenyl)sulfonyl](isobutyl)amino}-6-hydroxyhex yl]-Nα-(methoxycarbonyl)-β-phenyl-L-phenylalaninamide
英文别名 更多

 物理化学性质

分子式 C33H44N4O6S
分子量 624.79100
精确质量 624.29800
PSA 166.42000
LogP 6.82630

 合成线路

~%

N-[(1s)-1-[[[(5s)-5-[[(4-氨基苯基)磺酰基](2-甲基丙基)氨基]-6-羟基己基]氨基]羰基]-2,2-二苯基乙基]氨基甲酸甲酯结构式

N-[(1s)-1-[[[(5...

612547-11-2

文献:Stranix, Brent R.; Lavallee, Jean-Francois; Sevigny, Guy; Yelle, Jocelyn; Perron, Valerie; LeBerre, Nicholas; Herbart, Dominik; Wu, Jinzi J. Bioorganic and Medicinal Chemistry Letters, 2006 , vol. 16, # 13 p. 3459 - 3462

~%

N-[(1s)-1-[[[(5s)-5-[[(4-氨基苯基)磺酰基](2-甲基丙基)氨基]-6-羟基己基]氨基]羰基]-2,2-二苯基乙基]氨基甲酸甲酯结构式

N-[(1s)-1-[[[(5...

612547-11-2

文献:Stranix, Brent R.; Lavallee, Jean-Francois; Sevigny, Guy; Yelle, Jocelyn; Perron, Valerie; LeBerre, Nicholas; Herbart, Dominik; Wu, Jinzi J. Bioorganic and Medicinal Chemistry Letters, 2006 , vol. 16, # 13 p. 3459 - 3462

~%

N-[(1s)-1-[[[(5s)-5-[[(4-氨基苯基)磺酰基](2-甲基丙基)氨基]-6-羟基己基]氨基]羰基]-2,2-二苯基乙基]氨基甲酸甲酯结构式

N-[(1s)-1-[[[(5...

612547-11-2

文献:Stranix, Brent R.; Lavallee, Jean-Francois; Sevigny, Guy; Yelle, Jocelyn; Perron, Valerie; LeBerre, Nicholas; Herbart, Dominik; Wu, Jinzi J. Bioorganic and Medicinal Chemistry Letters, 2006 , vol. 16, # 13 p. 3459 - 3462

~%

N-[(1s)-1-[[[(5s)-5-[[(4-氨基苯基)磺酰基](2-甲基丙基)氨基]-6-羟基己基]氨基]羰基]-2,2-二苯基乙基]氨基甲酸甲酯结构式

N-[(1s)-1-[[[(5...

612547-11-2

文献:Stranix, Brent R.; Lavallee, Jean-Francois; Sevigny, Guy; Yelle, Jocelyn; Perron, Valerie; LeBerre, Nicholas; Herbart, Dominik; Wu, Jinzi J. Bioorganic and Medicinal Chemistry Letters, 2006 , vol. 16, # 13 p. 3459 - 3462

~%

N-[(1s)-1-[[[(5s)-5-[[(4-氨基苯基)磺酰基](2-甲基丙基)氨基]-6-羟基己基]氨基]羰基]-2,2-二苯基乙基]氨基甲酸甲酯结构式

N-[(1s)-1-[[[(5...

612547-11-2

文献:Stranix, Brent R.; Lavallee, Jean-Francois; Sevigny, Guy; Yelle, Jocelyn; Perron, Valerie; LeBerre, Nicholas; Herbart, Dominik; Wu, Jinzi J. Bioorganic and Medicinal Chemistry Letters, 2006 , vol. 16, # 13 p. 3459 - 3462

~%

N-[(1s)-1-[[[(5s)-5-[[(4-氨基苯基)磺酰基](2-甲基丙基)氨基]-6-羟基己基]氨基]羰基]-2,2-二苯基乙基]氨基甲酸甲酯结构式

N-[(1s)-1-[[[(5...

612547-11-2

文献:Stranix, Brent R.; Lavallee, Jean-Francois; Sevigny, Guy; Yelle, Jocelyn; Perron, Valerie; LeBerre, Nicholas; Herbart, Dominik; Wu, Jinzi J. Bioorganic and Medicinal Chemistry Letters, 2006 , vol. 16, # 13 p. 3459 - 3462

~%

N-[(1s)-1-[[[(5s)-5-[[(4-氨基苯基)磺酰基](2-甲基丙基)氨基]-6-羟基己基]氨基]羰基]-2,2-二苯基乙基]氨基甲酸甲酯结构式

N-[(1s)-1-[[[(5...

612547-11-2

文献:Stranix, Brent R.; Lavallee, Jean-Francois; Sevigny, Guy; Yelle, Jocelyn; Perron, Valerie; LeBerre, Nicholas; Herbart, Dominik; Wu, Jinzi J. Bioorganic and Medicinal Chemistry Letters, 2006 , vol. 16, # 13 p. 3459 - 3462

~%

N-[(1s)-1-[[[(5s)-5-[[(4-氨基苯基)磺酰基](2-甲基丙基)氨基]-6-羟基己基]氨基]羰基]-2,2-二苯基乙基]氨基甲酸甲酯结构式

N-[(1s)-1-[[[(5...

612547-11-2

文献:Stranix, Brent R.; Lavallee, Jean-Francois; Sevigny, Guy; Yelle, Jocelyn; Perron, Valerie; LeBerre, Nicholas; Herbart, Dominik; Wu, Jinzi J. Bioorganic and Medicinal Chemistry Letters, 2006 , vol. 16, # 13 p. 3459 - 3462

 英文别名

4-HYDROXY-6R-METHYL-1R,3,7S-TRIS(3-METHYL-2-BUTENYL)-5S-(2-METHYL-1-OXOPROPYL)-6R-(4-METHYL-3-PENTENYL)-BICYCLO[3.3.1]NON-3-ENE-2,9-DIONE
(1S,5S)-(1-{5-[(4-amino-benzenesulfonyl)-isobutyl-amino]-6-hydroxy-hexylcarbamoyl}-2,2-diphenyl-ethyl)-carbamic acid methyl ester
methyl-1,3,7-tris(3-methyl-2-buten-1-yl)-5-(2-methyl-1-oxopropyl)-6-(4-methyl-3-penten-1-yl)-,(1R,5S,6R,7S)
Bicyclo[3.3.1]non-3-ene-2,9-dione,4-hydroxy-6
(1S,5R,7S,8R)-4-hydroxy-8-methyl-3,5,7-tris(3-methylbut-2-enyl)-8-(4-methylpent-3-enyl)-1-(2-methylpropanoyl)bicyclo[3.3.1]non-3-en-2,9-dione
HYPERFORIN MIX(P)